Dr. Mark Edward Cormier , MD
Urology • Rockford, IL
351 Executive Pkwy
Rockford, IL 611075339
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 25, 2006; this date does not establish years in practice.
-
Published CMS data list 1,305 Original Medicare Part B services in 2022.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2022. Published rows only; this is not a quality measure.
-
Published Part B service records, 2022:
- 81003 — Automated urinalysis test: 287 service units.
- J9217 — Leuprolide acetate (for depot suspension), 7.5 mg: 198 service units.
- 99213 — Established patient outpatient office visit: 182 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2022. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2021 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2022). CPT notice
See all 16 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 143 Medicare Part D prescriptions, including refills, in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Published rows only; this is not a quality measure.
-
Published Part D records, 2023:
- Tamsulosin Hcl — 62 prescription fills, including refills.
- Methenamine Hippurate — 20 prescription fills, including refills.
- Finasteride — 18 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 6 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 3,109 in 2018 to 1,305 in 2022.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2018–2022.
Practice Location & Contact Primary Location
351 Executive Pkwy
Rockford, IL 611075339
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
331 people with Original Medicare in 2022
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2022.
Medicare-allowed amount
About $90,303 in 2022
The total amount Medicare approved for these services in 2022. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2022.
Paid by Medicare
About $66,362 in 2022
The part of the Medicare-allowed amount that Medicare itself paid in 2022, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2022.
30-day fills
335 standardized 30-day fills in 2023
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$18,479 in 2023
The total cost of these prescriptions in 2023, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023.
Open Payments general payments, program year 2025
All general payments: $68,233.26 across 23 records.
By nature of payment
- Consulting Fee: $68,233.26 across 23 records.
Reporting-company totals
- Takeda Pharmaceuticals U.S.A., Inc.: $68,233.26 across 23 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Cormier has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Cormier as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Rockford and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Cormier are from 2022.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Cormier are from 2023.
11 active clinicians are listed under Urology with a practice address in Rockford, IL (628 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Rockford
9.1% of these 11 clinicians have the CMS telehealth indicator.
27.3% of these 11 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 58% from 3,109 in 2018 to 1,305 in 2022.
- 2018: 3,109
- 2019: 2,917
- 2020: 4,314
- 2021: 4,511
- 2022: 1,305
-
Medicare-allowed amount
Medicare-allowed amount decreased 58% from $216,194 in 2018 to $90,303 in 2022.
- 2018: $216,194
- 2019: $230,142
- 2020: $203,888
- 2021: $171,378
- 2022: $90,303
-
Paid by Medicare
Paid by Medicare decreased 59% from $162,771 in 2018 to $66,362 in 2022.
- 2018: $162,771
- 2019: $173,103
- 2020: $151,164
- 2021: $129,599
- 2022: $66,362
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 91% from 1,612 in 2019 to 143 in 2023.
- 2019: 1,612
- 2020: 1,614
- 2021: 1,487
- 2022: 1,038
- 2023: 143
-
30-day fills
30-day fills decreased 90% from 3,274 in 2019 to 335 in 2023.
- 2019: 3,274
- 2020: 3,475
- 2021: 3,072
- 2022: 2,200
- 2023: 335
-
Part D drug cost
Part D drug cost decreased 97% from $697,781 in 2019 to $18,479 in 2023.
- 2019: $697,781
- 2020: $432,533
- 2021: $780,166
- 2022: $650,148
- 2023: $18,479
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $306.72 in 2021 to $68,233.26 in 2025.
- 2021: $306.72
- 2022: $374.74
- 2023: $22,843.34
- 2024: $60,701.01
- 2025: $68,233.26
Sources: CMS Medicare Physician & Other Practitioners (2022), CMS Medicare Part D Prescribers (2023), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 23 records totaling $68,233.26.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,133.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,033.33 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $500.00 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2021 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2022; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
81003
Automated urinalysis test
|
287 | 207 | $31.00 | $2.21 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
198 | 30 | $1000.00 | $171.17 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
182 | 150 | $175.00 | $87.75 |
|
36415
Insertion of needle into vein for collection of blood sample
|
117 | 91 | $28.00 | $2.97 |
|
84153
Psa (prostate specific antigen) measurement, total
|
114 | 89 | $100.00 | $17.92 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
79 | 73 | $192.00 | $9.76 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
61 | 50 | $590.00 | $235.19 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
60 | 57 | $250.00 | $123.92 |
|
51702
Simple insertion of temporary bladder tube
|
54 | 16 | $246.00 | $60.77 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
37 | 32 | $130.00 | $31.15 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
23 | 22 | $83.00 | $21.44 |
|
99442
Telephone medical discussion with physician, 11-20 minutes
|
22 | 21 | $130.00 | $85.13 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
21 | 21 | $280.00 | $111.12 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
19 | 19 | $375.00 | $165.86 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
17 | 16 | $120.00 | $55.39 |
|
99443
Telephone medical discussion with physician, 21-30 minutes
|
14 | 13 | $160.00 | $116.90 |
Source: CMS Part B by Provider and Service, 2022; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2023.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 62 | 5,460 | $1,810.26 | 41 |
| Methenamine Hippurate | Methenamine Hippurate | 20 | 905 | $2,799.40 | — |
| Finasteride | Finasteride | 18 | 1,443 | $236.29 | 11 |
| Myrbetriq | Mirabegron | 17 | 660 | $10,742.69 | — |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | 930 | $1,328.99 | — |
| Bicalutamide | Bicalutamide | 11 | 630 | $1,561.82 | — |
Source: CMS Part D by Provider and Drug, 2023; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20040624000278
IL
2668457433
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Osteopathic Medicine (D.O.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated January 25, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Urology Specialists in Rockford
- Dr. Christopher Whelan, MD
- Dr. Michael Fumo, MD
- Dr. Douglas Roegner, MD
- Dr. Warren Lowry, MD
- Dr. Daniel Houlihan, DO
- Dr. Luke Frederick, MD
Mailing Address
351 Executive Pkwy
Rockford, IL 611075339
Phone: 8153984057